Walleye Trading’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,453
| Closed | -$1.14M | – | 1167 |
|
|
2025
Q1 | $1.14M | Buy |
+33,453
| New | +$1.14M | ﹤0.01% | 325 |
|
|
2024
Q4 | – | Sell |
-8,870
| Closed | -$417K | – | 1249 |
|
|
2024
Q3 | $417K | Buy |
8,870
+7,173
| +423% | +$337K | ﹤0.01% | 515 |
|
|
2024
Q2 | $91.7K | Sell |
1,697
-3,510
| -67% | -$190K | ﹤0.01% | 950 |
|
|
2024
Q1 | $355K | Buy |
+5,207
| New | +$355K | ﹤0.01% | 744 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1885 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1866 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1668 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1752 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1880 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2018 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2047 |
|
|
2022
Q1 | – | Sell |
-4,793
| Closed | -$363K | – | 2092 |
|
|
2021
Q4 | $363K | Buy |
4,793
+4,711
| +5,745% | +$357K | ﹤0.01% | 933 |
|
|
2021
Q3 | $9K | Sell |
82
-10,390
| -99% | -$1.14M | ﹤0.01% | 1640 |
|
|
2021
Q2 | $1.7M | Buy |
+10,472
| New | +$1.7M | 0.01% | 295 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1688 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1520 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1224 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1244 |
|
|
2020
Q1 | – | Sell |
-2,718
| Closed | -$166K | – | 1252 |
|
|
2019
Q4 | $166K | Sell |
2,718
-4,197
| -61% | -$256K | ﹤0.01% | 909 |
|
|
2019
Q3 | $283K | Buy |
+6,915
| New | +$283K | ﹤0.01% | 628 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1229 |
|
|
2019
Q1 | – | Sell |
-20,791
| Closed | -$594K | – | 1230 |
|
|
2018
Q4 | $594K | Buy |
+20,791
| New | +$594K | ﹤0.01% | 590 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1864 |
|